On August 18th, 2015, the FDA approved Flibanserin (Addyi) to help premenopausal women who were experiencing low sexual desire that resulted in personal distress or difficulties. Taken in tablet form, this non-hormonal pill acts as a “multifunctional serotonin against antagonist” (MSAA) to provide treatment for those facing hypoactive sexual desire disorders. Whilst this may sound like a good idea on paper, the safety and testing behind this “female viagra'' is both dangerous and problematic.
Flibanserin, also called Addyi, went through the normal approval protocol, giving the illusion that it was safe for female consumption. It comes as a 100mg dose that should be taken daily right before bedtime. There are however multiple dangerous side effects that Flibanserin may cause which this 2018 paper goes into detail about. Administration during waking hours increased the chances of hypotension, syncope (passing out), accidental injury, and depression. Flibanserin “may also cause (CNS) depression with somnolence and sedation. Fatigue, insomnia, and dry mouth can also occur.” Those taking Flibanserin should not drive or engage in any activities that require full alertness until it has been at least 6 hours after taking flibanserin. At this point, I’m beginning to wonder how the heck this was even passed as a safe drug. But it gets a lot worse from here…


















